Treatment of brain injuries using cord blood stem cells

To determine the safety and efficacy of using human umbilical cord blood mesenchymal stem cells (MSCs) in treatment, MSCs were administered to a rat three days after suffering a stroke.

Following treatment, results showed a significant improvement in motor function and a reduction in ischemic damage.  Not only has the study proved the efficacy of MSCs in treatment, but also it is indicative of its feasibility in the treatment of brain injuries such as strokes or neurodegenerative disorders.